Clinical Trial Update: A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents [Phase 2]

View source ↗

Summary

Phase 2 open-label extension study evaluating perampanel (E2007) in adolescents with epilepsy, focusing on cognition, growth, safety, tolerability, and pharmaco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2019-05-15